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The surface activity and interaction with lipid monolayers and bilayers of the antitumour ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-
phosphocholine (edelfosine) have been studied. Edelfosine is a surface-active soluble amphiphile, with critical micellar concentrations at 3.5 μM
and 19 μM in water. When the air–water interface is occupied by a phospholipid, edelfosine becomes inserted in the phospholipid monolayer,
increasing surface pressure. This increase is dose-dependent, and reaches a plateau at ca. 2 μM edelfosine bulk concentration. The ether lipid can
become inserted in phospholipid monolayers with initial surface pressures of up to 33 mN/m, which ensures its capacity to become inserted into
cell membranes. Upon interaction with phospholipid vesicles, edelfosine exhibits a weak detergent activity, causing release of vesicle contents to a
low extent (b5%), and a small proportion of lipid solubilization. The weak detergent properties of edelfosine can be related to its very low critical
micellar concentrations. Its high affinity for lipid monolayers combined with low lytic properties support the use of edelfosine as a clinical drug.
The surface-active properties of edelfosine are similar to those of other “single-chain” lipids, e.g. lysophosphatidylcholine, palmitoylcarnitine, or
N-acetylsphingosine.
© 2007 Elsevier B.V. All rights reserved.Keywords: Antitumour lipid; Edelfosine; Surface activity; Lipid monolayers; Critical micellar concentration1. Introduction
The antitumour drug 1-O-octadecyl-2-O-methyl-rac-glycero-
3-phosphocholine (ET-18-OCH3, edelfosine) represents the
prototype of a group of synthetic antitumour ether lipids that
show promising and selective antitumour activity and that, unlike
most conventional chemotherapeutic drugs, do not target the
DNA [1–3]. Edelfosine is accumulated in lipid rafts in tumour
cells [4–6], and induces apoptosis through a redistribution of lipid
raft protein composition [4,7–9]. However, little is known about
the physical properties of edelfosine, and of its interaction with
membrane lipids. Its structure, containing defined hydrophobic
and hydrophilic moieties, suggests a potent surface activity, as
found with structurally related biomolecules, e.g. lysopho-⁎ Corresponding author. Fax: +34 94 601 33 60.
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doi:10.1016/j.bbamem.2007.04.025sphatidylcholine [10], palmitoylcarnitine [11], or N-acetylsphin-
gosine [12]. All these molecules partition preferentially into the
lipid bilayers in mixed aqueous dispersions of surfactant and
phospholipid vesicles and some, e.g. N-acetylsphingosine, have a
mild detergent activity, i.e. they are able to form phospholipid–
surfactant mixed micelles [13]. Sánchez-Piñera et al. [14]
described the effects of edelfosine on the polymorphic properties
of dielaidoylphosphatidylethanolamine, demonstrating clear
effects of the ether–lipid on the phospholipid phase behaviour.
More recently, Torrecillas et al. [15] have described the effects of
edelfosine and various analogues on the thermotropic phase
transitions of phospholipids.
The present study is aimed at describing the surface-active
properties of edelfosine in aqueous and bilayer environments.
This ether lipid is found to interact with pure phosphatidylcho-
line monolayers and bilayers. Some of these properties may be
relevant in the antitumour activity of edelfosine.
Fig. 1. Edelfosine-induced changes in surface pressure at an air–water interface.
(A) Time course. Representative π vs. time curves, the figures correspond to
bulk edelfosine concentrations (μM). (B) Equilibrium values obtained from
experiments as those shown in panel A. Average values±S.E. (n=3). Subphase
composition was 10 mM HEPES, 150 mM NaCl, pH 7.4. Edelfosine was
injected into the subphase.
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Edelfosine was obtained from INKEYSA (Barcelona, Spain). 1-Palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC) was supplied by Avanti Polar
Lipids (Alabaster, AL). Egg yolk phosphatidylcholine (ePC) was grade I from
Lipid Products (South Nutfield, UK). 2-Anilinonaphthalene-6-sulphonic acid
(ANS), lissamine™ rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-phos-
phoethanolamine triethylammonium salt (rhodamine DHPE), 8-aminonaphtha-
lene-1,3,6-trisulfonic acid (disodium salt) (ANTS) and p-xylene-bis-pyridinium
bromide (DPX) were from Molecular Probes, Inc. (Eugene, OR). Merocyanine
540 and Triton X-100 were provided by Sigma (St. Louis, MO). All assays were
carried out in 10 mMHEPES, 150 mMNaCl, pH 7.4 buffer. All lipids were used
without further purification. All other reagents were of analytical grade.
For liposome preparation, the proper amount of lipid was dissolved in
chloroform:methanol (2:1, v/v) solution and the solvent evaporated exhaustive-
ly. Multilamellar vesicles (MLVs) were then prepared by hydrating the lipid film
with buffer by vigorous vortexing. Large unilamellar vesicles (LUVs) were
prepared by the extrusion method, passing the MLV suspension 10 times
through polycarbonate filters 0.1 μm in pore diameter. Average size of the
vesicles was ca. 0.1 μm as measured by quasi-elastic light scattering in a
Malvern Zeta-Sizer 4 spectrometer. Final lipid concentration was measured in
terms of lipid phosphorus.
2.1. Lipid monolayers and fluorescence measurements
Monomolecular layers at the interface were studied at 22 °C using a
μTrough-S equipment (Kibron, Helsinki, Finland) consisting on a small 2-cm
rounded multi-well plate that allowed for 1 mm subphase measurements.
Monolayers were formed by spreading a small amount of lipid (about 2 nmol) in
chloroform:methanol (2:1, v/v) solution over assaying buffer. After allowing for
solvent evaporation, edelfosine in buffer was added into the subphase through an
adjusted hole. When formation of edelfosine monolayer was tested edelfosine
was injected into the subphase without previous lipid spreading, following
edelfosine transition to the interface in terms of changes in surface pressure. For
fluorescence measurements, Rh-PE monolayers were formed at the interface at
π=20 mN/m and edelfosine was then injected into the subphase. After
equilibration, aliquots were extracted from the subphase and assayed for
rhodamine fluorescence by using an Aminco Bowman Series 2 luminescence
spectrometer. The Rh-PE emission was followed at 590 nm (excitation
wavelength at 530 nm) with a cut-off filter at 560 nm. Buffer was used as a
zero for fluorescence signal.
2.2. CMC determination
Critical micellar concentration was measured at 22 °C by mixing
increasing concentrations of edelfosine in water (0 to 34 μM) with the
hydrophobic dye Merocyanine 540 (final concentration 4 μM) [16]. Absorp-
tion spectra from the samples was then measured in an Uvikon 922
spectrophotometer and cmc was determined by an increase of about 25 nm in
the absorption maximum wavelength (λmax) of the dye upon merocyanine
entrapping into edelfosine micelles. Alternatively, edelfosine was mixed with
the fluorescent probe ANS (final concentration 2 μM) [16 bis], and ANS
fluorescence emission was measured in a SLM-AMINCO 8100 spectrofluoro-
meter (λex=390 nm, λem=550 nm). In the ANS method the cmc is determined
from an abrupt increase in fluorescence emission intensity.
2.3. Vesicle content efflux measurement
Large unilamellar vesicles were prepared in the presence of ANTS and DPX
[17]. The lipid suspension was passed through a Sephadex G-25 column to
discard non-encapsulated dye. Final lipid concentration was always 0.3 mM.
Vesicle content efflux was measured at 22 °C in an Aminco Bowman Series 2
luminescence spectrometer by following ANTS externalization after edelfosine
addition. ANTS emission was recovered at 520 nm (excitation wavelength at
355 nm) with a cut-off filter at 450 nm. Initial vesicle suspension was used as the
0% fluorescence signal while 100% fluorescence was obtained after breakdown
of the vesicles by addition of 1 mM Triton X-100.2.4. Solubilization assays
Liposome suspensions were prepared in sucrose buffer (10 mM HEPES,
255 mM sucrose, pH 7.4) and diluted 10 times in assay buffer to diminish non-
encapsulated sucrose concentration for a proper sedimentation. Sucrose-
containing vesicles were ultracentrifuged for 1 h at 100,000×g and 4 °C, and
the supernatant discarded. The pellet was resuspended in assay buffer and mixed
with the same volumes of the appropriate edelfosine solutions in the same
sucrose-free buffer. Final lipid vesicle concentration was always 1 mM. The
mixtures were left to equilibrate for 1 h at 22 °C, and solubilization was assayed
from changes in turbidity. Turbidity was measured as absorbance at 500 nm
(A500) in an Uvikon 922 spectrophotometer. Turbidity values were normalized
by setting 100% as the turbidity of the LUV suspension in the absence of
edelfosine, while 0% turbidity corresponded to pure buffer [18]. After turbidity
measurements, the solutions were again ultracentrifuged for 1 h at 125,000×g
and 4 °C, and vesicle solubilization followed in terms of lipid phosphorus in the
supernatant.3. Results
The surface-active properties of edelfosine were tested in a
Langmuir balance. The ether lipid suspended in buffer was
injected into the subphase, and the change in surface pressure
(π) was recorded. Edelfosine caused a dose-dependent increase
in surface pressure. Representative curves of π vs. time are
shown in Fig. 1A. After a certain time, that decreased with
increasing edelfosine concentrations, π remained constant. This
constant value was operationally defined as an equilibrium
value in this context. Equilibrium values of edelfosine-induced
Fig. 3. Insertion of edelfosine into POPC monolayers oriented at the air–water
interface. (A) Representative time courses of the changes in surface pressure
upon injection of edelfosine (μM concentrations indicated for each curve) into
the subphase and subsequent insertion into the monolayer. (B) Equilibrium
values of edelfosine-induced surface pressure changes. Subphase composition
as in Fig. 1. Average values±S.E. (n=3).
Fig. 2. Critical micellar concentrations of edelfosine. The cmcs, indicated by the
arrows, were estimated from the abrupt changes in the absorption maximum
wavelength of merocyanine 540 (A) or in the ANS fluorescence emission
intensity (B) as edelfosine concentrations were increased. Average values±S.E.
(n=3).
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in Fig. 1B. These values increased with ether–lipid concentra-
tion up to ≈10 μM, and remained constant above that
concentration. This represents probably the concentration at
which edelfosine micelles start being formed, so that a regime of
monomers-in-solution in equilibrium with monomers-at-the-
interface is being replaced by a more complex equilibrium
between monomers (interface), monomers (solution) and
micelles (solution). In other words, the results in Fig. 1 show
that edelfosine is a surface-active lipid with a critical micellar
concentration (cmc) in the 5–10 μM range.
The cmc of edelfosine was studied in more detail using either
the merocyanine 540 method of Kaschny and Goñi [16] or the
ANS method [16 bis]. With merocyanine the cmc of surfactants
is marked by an abrupt increase (of about 25 nm) in the
absorption maximum wavelength (λmax) corresponding to the
merocyanine 540 monomer. The results in Fig. 2A indicate in
fact two, rather than one, increases in λmax, corresponding
probably to two different aggregation phenomena, i.e. forma-
tion of smaller and larger micelles. The observation of two cmcs
for a given surfactant is unusual. This sort of behaviour was
recently described by us for the short-chain ceramides [13]. The
data in Fig. 2A indicated cmcs in buffer at 3.0 μM and 13 μM
respectively. Cmc measurements performed with the ANS
method provided very similar values (Fig. 2B). The cor-
responding studies carried out in water gave values of 3.0 μM
and 13 μM irrespective of the method used (data not shown).The cmc observed at 3.0 μM by the merocyanine and ANS
methods (Fig. 2) corresponds probably to the one detected at
5–10 μM with the Langmuir balance (Fig. 1). It is known that
the so-called critical micelle concentration occurs in fact over
a range of surfactant concentrations, and that the precise value
obtained depends on the technique used, as well as on buffer,
temperature, etc. [19].
The insertion of edelfosine into phospholipid monolayers
was tested using again the Langmuir balance, with preformed
POPC monolayers at the air–buffer interface, and edelfosine
injected into the subphase. POPC in excess water gave rise
spontaneously to lipidic bilayers, thus it can be considered as a
typical biomembrane phospholipid. Edelfosine insertion into a
POPC monolayer at 20 mN/m increases lateral pressure in a
dose-dependent form, as indicated in Fig. 3. The π vs.
edelfosine concentration curves reach a plateau at ca. 2–4 μM
edelfosine. Again the behaviour of the ether lipid was very
similar to the one observed for short-chain (N-acetyl) ceramide
[13]. Edelfosine insertion-dependent increases in lateral pres-
sure depend strongly on the initial π value. The plateau values
of surface pressure increase (▵π) after edelfosine insertion are
plotted as a function of initial π in Fig. 4. The data can be fitted
to a straight line, whose extrapolation to▵π=0 gives an idea of
the maximummonolayer surface pressure that allows edelfosine
insertion into monolayers. Edelfosine may become inserted into
monolayers at initial π up to ≈32 mN/m. This is important
Fig. 6. Release of vesicle aqueous contents induced by edelfosine. Egg PC
vesicles loaded with ANTS/DPX were treated with increasing amounts of the
ether lipid. 100% release was measured in the presence of excess Triton X-100.
Average values±S.E. (n=3).
Fig. 4. Changes in surface pressure of POPCmonolayers as a result of edelfosine
insertion, at varying initial pressures. Average values±S.E. (n=3).
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pressure π ≈30 mN/m [20], albeit with large fluctuations
around this average value. Thus the data in Fig. 4 indicate that
edelfosine can insert easily into cell membranes, in agreement
with its well-known effects at the cellular level.
The π vs. time curves in Fig. 3A show a maximum surface
pressure that is achieved shortly after injection, then π values
decrease slowly to their equilibrium values. This represents
probably a fast partitioning of edelfosine into the monolayer,
followed by a slow dispersion in the bulk water. The latter
observation suggests in turn that edelfosine, above a given
concentration, starts solubilizing the POPC monolayers, giving
rise to POPC:edelfosine mixed micelles. This hypothesis was
tested using a fluorescent phospholipid derivative, namely Rh-
PE, whose behaviour in monolayers is very similar to that of
POPC (data not shown). Rh-PE monolayers were formed at an
initial π=20 mN/m and edelfosine was injected into the sub-
phase at bulk concentrations in the 0–50 μM concentration
range. After allowing for equilibration, aliquots of the subphase
were withdrawn and rhodamine fluorescence assayed. As shown
in Fig. 5, the ether lipid brought about the solubilization of Rh-
PE. The presence of Rh-PE fluorescence in the aqueous phase
can explain the decrease in surface pressure observed in Fig. 3A.
In view of the ability of edelfosine to solubilize phospho-
lipids in monolayers, a number of experiments were performedFig. 5. Solubilization of Rh-PE monolayers by edelfosine. The ether lipid was
injected into the subphase of monolayers of Rh-PE at an initial π=20 mN/m.
After equilibration, aliquots of the subphase were removed and rhodamine
fluorescence assayed. Average values±S.E. (n=3).next in which phospholipids were present in the form of
bilayers. The capacity of edelfosine to break down the bilayer
permeability barrier was tested using ePC large unilamellar
vesicles in which ANTS/DPX had been entrapped. Edelfosine
addition caused a dose-dependent, reproducible, though small
release of vesicle aqueous contents (Fig. 6). Contents release
was only detected above 18 μM edelfosine, i.e. above the
second cmc as observed in Fig. 2. Bilayer solubilization was
assayed using two different methods, namely decrease in vesicle
suspension turbidity and assay of lipid P in the supernatantsFig. 7. Solubilization of ePC vesicles by edelfosine. (A) Ether lipid-induced
decrease in vesicle suspension turbidity (A500). (B) Percent lipid P recovered in
the supernatant after centrifugation of the edelfosine-treated vesicles. Average
values±S.E. (n=3).
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because of its convenience, even if the results obtained are not
quantitative [21]. The vesicles were incubated with the appro-
priate amounts of edelfosine and solubilization was observed as
a decrease in vesicle suspension turbidity (Fig. 7A). Again lipid
bilayers are seen to be perturbed by the surfactant only at
concentrations above the second cmc detected in Fig. 2.
Turbidity reaches a plateau when most of the bilayers remain
non-solubilized. Higher edelfosine concentrations or higher
incubation times failed to cause further decreases in turbidity.
Vesicle solubilization was also assayed by centrifuging the
surfactant-treated vesicles and assaying the fraction of lipid P
remaining in the supernatant. The latter is assumed to be in the
form of lipid-detergent mixed micelles. Vesicles loaded with
concentrated sucrose were used in this experiment, in order to
facilitate their sedimentation. The results in Fig. 7B show, in
agreement with the turbidity data (Fig. 7A), that only a small
fraction of the vesicles is solubilized. The capacity of edelfosine
to bring about the bilayer–micelle transition is smaller than that
of the short-chain ceramides [13].
4. Discussion
The ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-
phosphocholine, known as edelfosine, is an interesting anti-
cancer drug because of its promising antitumour proapoptotic
properties and its rather peculiar mechanism of action affecting
the cell membrane [1,3,4]. In this study we have found that
edelfosine is a surfactant molecule, that inserts readily into lipid
monolayers and bilayers, and displays a low detergent activity.
Edelfosine should be considered as an amphiphile, because
its molecule contains both lipophilic and hydrophilic moieties.
In his classification of amphiphiles, Small [22] distinguished
between non-swelling, swelling and soluble amphiphiles.
According to the results in this paper, edelfosine should be
classified as a “soluble amphiphile”, mainly because it can be
easily dispersed in water, up to at least 100 mM, giving rise to
optically clear or slightly opalescent suspensions, and showing a
discrete monomer–micelle transition. Other soluble amphiphiles
include biomolecules such as the lysophospholipids, platelet-
activating factor, or fatty acylcarnitines.
The soluble amphiphiles include also the commonly used
detergents [23]. However, not all soluble amphiphiles have
comparable detergent activities, i.e. not all of them are able to
solubilize bilayers giving rise to lipid–detergent mixed
micelles. Detergents used in membrane studies have cmc
above 100 μM, and often above 1 mM [19,24]. The cmc is,
among other things, a measure of the affinity of the amphiphile
molecules for each other, a higher affinity corresponding to a
lower cmc. Apparently, very low cmcs suggest such a high
affinity of the surfactant molecules for each other that their
micelles can hardly accept a different amphiphile, i.e. the
phospholipid, to generate mixed micelles, i.e. bilayer solubi-
lization. The latter property is found in amphiphiles with a
higher cmc. Lysophosphatidylcholines have cmcs in the 40–
50 μM range, the corresponding value for palmitoylcarnitine is
around 10 μM [25], and, as shown in this paper, edelfosine hascmcs at ca. 3.5 μM and 19 μM. The latter three amphiphiles
are very poor at solubilizing bilayers, as compared with, e.g.
Triton X-100 (cmc ≈370 μM). It is interesting in this context
that the mild detergent properties of edelfosine are only
apparent above the highest of its two cmcs (Figs. 6 and 7). A
low detergent activity of edelfosine has also been proposed by
Torrecillas et al. [15]. The same authors have observed that
edelfosine facilitates the lamellar–hexagonal transition of
phosphatidylethanolamines. This would be in agreement with
the expected molecular shape of a micelle-forming molecule,
like edelfosine. It goes without saying that a high detergent
potency would preclude the use of edelfosine as a clinical drug.
The results reported here showing the ready incorporation of
edelfosine into membranes provide an explanation for the fact
that this drug modifies plasma membrane lipid composition,
resulting in selective association or/and displacement of crucial
proteins with lipid raft scaffolds [4,8,9,15]. The current findings
on the weak detergent properties of edelfosine also give bio-
physical support to its specific and selective action on tumour
cells [2].
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